Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Protokinetix Inc (OP: PKTX )

0.0275 UNCHANGED
Streaming Delayed Price Updated: 2:19 PM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0275
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0275
Today's Range 0.0275 - 0.0275
52wk Range 0.0180 - 0.0750
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AIM ImmunoTech, InnSuites Hospitality Trust And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed higher on Wednesday following the release of Fed minutes. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their... 
Via Benzinga
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants
From ProtoKinetix, Incorporated
Via Business Wire

Performance

YTD
-8.03%
-8.03%
1 Month
-8.03%
-8.03%
3 Month
+25.57%
+25.57%
6 Month
-28.94%
-28.94%
1 Year
-59.56%
-59.56%

More News

Read More
Around $12 Million Bet On Sonim Technologies? 4 Penny Stocks Insiders Are Buying
Via Benzinga
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only
From ProtoKinetix, Incorporated
Via Business Wire
4 Penny Stocks Insiders Are Buying
Via Benzinga
ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease
From ProtoKinetix, Incorporated
Via Business Wire
4 Penny Stocks Insiders Are Buying
Via Benzinga
ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions
From ProtoKinetix, Incorporated
Via Business Wire
ProtoKinetix Announces the Resumption of Phase 1b Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 Diabetes
From ProtoKinetix, Incorporated
Via Business Wire
ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®
From ProtoKinetix, Incorporated
Via Business Wire
Journal of Tissue Engineering and Regenerative Medicine Publishes Peer Reviewed Research Paper Establishing ProtoKinetix AAGP® Enhanced Stem Cell Vision Restoration
From ProtoKinetix, Incorporated
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.